[1]徐晨,丁来霞,孙培养,等.西药联合明目汤治疗原发性闭角型青光眼视神经损害患者临床观察[J].西部中医药,2025,38(12):113-116.[doi:10.12174/j.issn.2096-9600.2025.12.22]
 XU Chen,DING Laixia,SUN Peiyang,et al.Clinical Observation on Western Medicine Joined with Eyesight-improving Decoction in the Treatment of Optic Nerve Damage in Primary Angle-closure Glaucoma Patients[J].Western Journal of Traditional Chinese Medicine,2025,38(12):113-116.[doi:10.12174/j.issn.2096-9600.2025.12.22]
点击复制

西药联合明目汤治疗原发性闭角型青光眼视神经损害患者临床观察()

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年12期
页码:
113-116
栏目:
衷中参西
出版日期:
2025-12-15

文章信息/Info

Title:
Clinical Observation on Western Medicine Joined with Eyesight-improving Decoction in the Treatment of Optic Nerve Damage in Primary Angle-closure Glaucoma Patients
作者:
徐晨1, 丁来霞1, 孙培养2, 丁凤3, 王芳1
1.南京同仁医院,江苏 南京 211102
2.安徽中医药大学第二附属医院 安徽 合肥 230061
3.安徽省含山县中医院,安徽 含山 238100
Author(s):
XU Chen1, DING Laixia1, SUN Peiyang2, DING Feng3, WANG Fang1
1.Nanjing Tongren Hospital, Nanjing 211102, China
2.The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230061, China
3.Hanshan County Hospital of TCM, Hanshan 238100, China
关键词:
青光眼闭角型原发性视神经损害明目汤眼压视神经功能
Keywords:
glaucoma angle-closure primaryoptic nerve damageeyesight-improving decoctionintraocular tensionoptic nerve function
分类号:
R276.5
DOI:
10.12174/j.issn.2096-9600.2025.12.22
文献标志码:
B
摘要:
目的探讨原发性闭角型青光眼(primary angle-closure glaucoma,PACG)视神经损害应用西药联合明目汤的治疗方法,并分析其治疗效果。 方法选择120例PACG患者,采用随机数字表法分为对照组和观察组,每组60例。对照组予常规西药治疗,观察组在对照组的基础上予明目汤治疗,两组均连续治疗4周。比较两组临床疗效及治疗前后视野检查结果[视野缺损程度(mean deviation,MD)、中心视野平均光敏度(mean sensitivity,MS)]、眼压、视网膜中央动脉血流指标[阻力指数(resistive index,RI)、收缩期血流峰值速度(peak systolic velocity,PSV)、舒张末期血流速度(end-diastolic velocity,EDV)]、视神经功能指标[潜伏期、振幅的图形视觉诱发电位(pattern visual evoked potential,P-VEP)]的变化。 结果治疗后,观察组治疗有效率[96.67(58/60)]高于对照组[83.33(50/60)](P<0.05);两组患者MD、眼压、RI、潜伏期P-VEP均较治疗前降低(P<0.05),MS、PSV、EDV、振幅P-VEP均升高(P<0.05),且观察组改善程度大于对照组(P<0.05)。 结论应用西药联合明目汤治疗PACG视神经损害,可有效提高临床疗效,降低眼压,改善视网膜中央动脉血流,从而促进视神经功能恢复。
Abstract:
ObjectiveTo explore the therapeutic methods of combining Western medicine with eyesight-improving decoction for optic nerve damage in primary angle-closure glaucoma (PACG) patients, and to analyze its therapeutic effects. MethodsA total of 120 PACG patients were selected and allocated to the control group and the observation group using random number table method with 60 cases in each. The control group was treated with conventional Western medicine while eyesight-improving decoction was administered to the observation group, both groups were treated for four consecutive weeks. To compare clinical effects, results of visual inspection before and after the treatment (MD, MS), intraocular tension and blood flow indexes of central retinal artery (CRA) (RI, PSV and EDV) and the indexes of optic nerve function (incubation period, P-VEP) in the two groups. ResultsAfter the treatment, the effective rate of the observation group was [96.67%(58/60)], higher than [83.33%(50/60)] of the control group (P<0.05); MD, intraocular tension, RI and P-VEP of incubation period were lower in the two groups than before the treatment (P<0.05), MS, PSV and EDV, alongside amplitude P-VEP were elevated (P<0.05), and the improvements of the observation group were larger than these of the control group (P<0.05). ConclusionCombining Western medicine with eyesight-improving decoction for optic nerve damage in PACG patients could effectively boost clinical effects, reduce intraocular tension, and improve blood flow indexes of CRA, thereby promoting the recovery of optic nerve function.

相似文献/References:

[1]王锦蓉.青光眼患者社会支持与心理状态评定分析[J].西部中医药,2012,25(05):51.
 WANG Jin-rong.Analysis on Social Support and Psychological Assessment of Glaucoma Patients[J].Western Journal of Traditional Chinese Medicine,2012,25(12):51.
[2]姜颖,曹林.护理干预对青光眼患者就医情绪及满意度的影响[J].西部中医药,2014,27(04):127.
 JIANG Ying,CAO Lin.Effects of Nursing Intervention on Satisfactory Degree and the Mood of Glaucoma Patients[J].Western Journal of Traditional Chinese Medicine,2014,27(12):127.
[3]刘 莹,马银虎△.“治未病”思想在青光眼防治中的应用[J].西部中医药,2012,25(10):86.
 LIU Ying,MA Yin-hu.Application of “Preventive Treatment of Disease" Thinking in the Prevention of Glaucoma[J].Western Journal of Traditional Chinese Medicine,2012,25(12):86.
[4]张诚,张殷建△.青光眼视神经节细胞内外源性凋亡机制及中西医保护研究新进展[J].西部中医药,2017,30(01):134.
 ZHANG Cheng,ZHANG Yinjian.Endogenous and Exogenous Apoptosis Mechanism of Retinal Ganglion Cells of Glaucoma Patients and New Progress of Integrative Traditional Chinese and Western Medicine Protection Study[J].Western Journal of Traditional Chinese Medicine,2017,30(12):134.
[5]张小英,吴娟,刘洁.穴位注射复方樟柳碱注射液联合针灸治疗青光眼视神经萎缩的效果观察[J].西部中医药,2020,33(06):116.[doi:10.12174/j.issn.1004-6852.2020.06.31]
 ZHANG Xiaoying,WU Juan,LIU Jie.Clinical Observation on Acupoint Injection of Compound Anisodine Injection Combined with Acupuncture in Treating Glaucomatous Optic Atrophy[J].Western Journal of Traditional Chinese Medicine,2020,33(12):116.[doi:10.12174/j.issn.1004-6852.2020.06.31]
[6]邓向花,曹亚,徐玲亚,等.循证护理对原发性闭角型青光眼手术患者心理健康和睡眠质量的影响[J].西部中医药,2014,27(10):133.
[7]夏湘君,曹亚,徐玲亚,等.循证护理应用于原发性闭角型青光眼患者的效果观察[J].西部中医药,2014,27(12):126.

备注/Memo

备注/Memo:
全国名老中医药专家传承工作室项目(国中医药人教函〔2022〕75号)。徐晨(1994—),女,硕士学位,主治医师。研究方向:眼科疾病的临床诊治及研究。
更新日期/Last Update: 2025-12-15